Published in J Exp Med on August 02, 1999
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med (2002) 2.92
Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood (2008) 2.76
AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med (2002) 1.65
Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog (2013) 1.59
Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci U S A (2002) 1.57
Microglia development and function. Annu Rev Immunol (2014) 1.41
Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. J Exp Med (2006) 1.37
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J Clin Invest (2013) 1.33
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. Adv Cancer Res (2015) 1.25
Oncogenic signaling: new insights and controversies from chronic myeloid leukemia. J Exp Med (2007) 1.13
Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein. Mol Cell Biol (2006) 1.07
IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res (2011) 1.05
DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells. Mol Cancer Res (2008) 1.04
Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. J Biol Chem (2013) 1.02
The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8. PLoS Pathog (2013) 1.00
IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. Neoplasia (2012) 0.99
IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation. J Immunol (2015) 0.96
IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Res (2009) 0.96
Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. J Cell Mol Med (2009) 0.94
Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun (2000) 0.93
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood (2010) 0.91
Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells. J Neuroinflammation (2011) 0.88
Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells. J Immunol (2011) 0.86
Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance. J Exp Med (2013) 0.85
Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells. Cell Death Dis (2014) 0.82
CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages. BMC Cancer (2014) 0.81
Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding. J Hematol Oncol (2014) 0.81
GAAP-1: a transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity. EMBO Rep (2002) 0.81
Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity. PLoS One (2012) 0.79
Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions. J Interferon Cytokine Res (2016) 0.79
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72
Caspases: enemies within. Science (1998) 19.45
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (1994) 11.50
A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem (1997) 9.97
Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell (1995) 9.11
Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A (1997) 7.25
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science (1992) 5.71
Double identity for proteins of the Bcl-2 family. Nature (1997) 5.60
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell (1994) 5.25
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol (1991) 5.02
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (1996) 4.92
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell (1993) 4.46
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23
Molecular cloning of the interleukin-1 beta converting enzyme. Science (1992) 4.19
Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res (1993) 4.11
Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell (1996) 4.04
Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell (1994) 3.56
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1990) 3.53
Apoptotic pathways: the roads to ruin. Cell (1998) 3.44
A license to kill. Cell (1996) 3.37
The growing family of interferon regulatory factors. Cytokine Growth Factor Rev (1997) 3.33
A signaling pathway to translational control. Cell (1996) 3.29
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J (1998) 2.82
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (1995) 2.79
IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol (1997) 2.70
Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science (1993) 2.63
ICE family proteases: mediators of all apoptotic cell death? Immunity (1996) 2.54
Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood (1991) 2.22
ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem (1996) 2.20
Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol (1993) 2.02
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A (1994) 1.98
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood (1994) 1.91
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood (1998) 1.80
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol (1997) 1.75
Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J Biol Chem (1993) 1.74
Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem (1997) 1.70
Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest (1997) 1.65
Controlling cell death. Science (1997) 1.64
Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J Biol Chem (1992) 1.59
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med (1996) 1.56
CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J (1996) 1.42
Transducing signals of life and death. Curr Opin Cell Biol (1997) 1.25
BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood (1993) 1.23
Apoptosis: Bcl-2-related proteins get connected. Curr Biol (1997) 1.23
Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element. J Virol (1995) 1.19
An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest (1996) 1.14
Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro. Mol Cell Biol (1996) 1.07
Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia (1996) 1.04
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. Transplantation (1995) 1.00
Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Dev (1997) 0.94
Mechanisms of apoptotic cell death. Leukemia (1997) 0.93
IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression. Clin Exp Immunol (1997) 0.92
IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters. Int Immunol (1994) 0.91
Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells. J Leukoc Biol (1996) 0.90
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol (1994) 0.88
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2. Eur J Immunol (1996) 0.87
A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs. J Immunol (1996) 0.86
A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis. Cell Growth Differ (1995) 0.84
Cell death in the myeloid lineage. Immunol Rev (1994) 0.81
Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc. Clin Immunol Immunopathol (1994) 0.79
cAMP and 'death signals' in a myeloid leukaemia cell: from membrane receptors to nuclear responses: a review. Biochem Soc Trans (1997) 0.76
The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia. Leukemia (1996) 0.76
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol (1981) 6.75
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature (1990) 4.69
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A (1993) 4.56
A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol Cell Biol (2000) 4.27
Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation (1982) 4.11
Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. Proc Natl Acad Sci U S A (1982) 3.73
Displacement of sequence-specific transcription factors from mitotic chromatin. Cell (1995) 3.71
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1990) 3.53
Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol (1980) 3.39
Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature (1982) 3.34
Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev (1992) 3.30
H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J (1992) 3.21
Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol (1992) 3.10
Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med (1985) 2.87
Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J Immunol (1982) 2.78
Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc Natl Acad Sci U S A (1989) 2.63
The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58
Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol (1986) 2.57
Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci U S A (1985) 2.56
Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J Immunol (1986) 2.51
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction (1998) 2.47
Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature (1987) 2.45
Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J Immunol (1983) 2.45
Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu. Science (1987) 2.44
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell (2001) 2.43
Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol (1989) 2.41
Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)). J Biol Chem (1997) 2.41
Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol (1992) 2.35
Synthesis of epothilones A and B in solid and solution phase. Nature (1997) 2.35
ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity (2000) 2.34
v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl Acad Sci U S A (1989) 2.34
apterous, a gene required for imaginal disc development in Drosophila encodes a member of the LIM family of developmental regulatory proteins. Genes Dev (1992) 2.33
Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood (2000) 2.30
PDGF-D, a new protease-activated growth factor. Nat Cell Biol (2001) 2.17
A mouse gene on chromosome 5 that restricts infectivity of mink cell focus-forming recombinant murine leukemia viruses. J Exp Med (1983) 2.08
The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol (1993) 2.06
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med (1988) 2.06
H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc Natl Acad Sci U S A (1989) 2.05
Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J Immunol (1988) 2.04
Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol (1993) 2.02
XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. J Immunol (1979) 2.02
Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med (1989) 2.02
Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J Exp Med (1987) 2.00
Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. Proc Natl Acad Sci U S A (2000) 1.99
The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene (1991) 1.98
Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS (1992) 1.97
Molecular organization of the decapentaplegic gene in Drosophila melanogaster. Genes Dev (1990) 1.96
Burkitt lymphoma in the mouse. J Exp Med (2000) 1.96
Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol (1988) 1.95
Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem (1998) 1.93
Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.90
A unique series of lymphomas related to the Ly-1+ lineage of B lymphocyte differentiation. J Immunol (1984) 1.89
Murine hematopoietic cells with pre-B or pre-B/myeloid characteristics are generated by in vitro transformation with retroviruses containing fes, ras, abl, and src oncogenes. J Exp Med (1986) 1.88
Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem (2001) 1.82
An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol (2000) 1.82
A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science (1991) 1.80
Interferons increase transcription of a major histocompatibility class I gene via a 5' interferon consensus sequence. Mol Cell Biol (1987) 1.78
The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding. J Immunol (1984) 1.77
Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J Biochem (1996) 1.77
The Drosophila EGF receptor gene homolog: conservation of both hormone binding and kinase domains. Cell (1985) 1.76
The medaka rs-3 locus required for scale development encodes ectodysplasin-A receptor. Curr Biol (2001) 1.75
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med (1997) 1.73
Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc Natl Acad Sci U S A (1988) 1.73
Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J Virol (1987) 1.72
Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem (1997) 1.70
Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J Virol (1991) 1.70
The COP9 signalosome is essential for development of Drosophila melanogaster. Curr Biol (1999) 1.70
Phenotypic characteristics of cell lines requiring interleukin 3 for growth. J Immunol (1982) 1.67
Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells. Proc Natl Acad Sci U S A (1983) 1.67
Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65
Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res (2001) 1.64
Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med (1997) 1.64
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol (1998) 1.62
CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol (1992) 1.62
Characteristics of B cell proliferation and activation in murine AIDS. J Immunol (1989) 1.61
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol (2000) 1.61
Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc Natl Acad Sci U S A (1985) 1.61
Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J Biol Chem (1992) 1.59
Binding of multiple nuclear factors to the 5' upstream regulatory element of the murine major histocompatibility class I gene. Mol Cell Biol (1987) 1.59
Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci (1985) 1.58
Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts. J Immunol (1986) 1.58
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res (1997) 1.56
DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat Genet (1997) 1.55
The see-through medaka: a fish model that is transparent throughout life. Proc Natl Acad Sci U S A (2001) 1.54
Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet (2000) 1.51
Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity (1997) 1.51
Biologic properties of rat antibodies. I. Antigen-binding by four classes of anti-DNP antibodies. J Immunol (1968) 1.50
Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science (1976) 1.50
Biologic properties of rat antibodies. 3. Histamine release mediated by two classes of antibodies. J Immunol (1969) 1.49
Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two cis-acting elements during induction. Mol Cell Biol (1989) 1.49
Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum Mol Genet (1993) 1.48